Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,091Revenue $M2,323Net Margin (%)34.9Z-Score10.4
Enterprise Value $M14,097EPS $7.5Operating Margin %-43.1F-Score7
P/E(ttm))18.6Cash Flow Per Share $2.6Pre-tax Margin (%)49.3Higher ROA y-yY
Price/Book7.010-y EBITDA Growth Rate %21.8Quick Ratio4.6Cash flow > EarningsY
Price/Sales6.55-y EBITDA Growth Rate %28.0Current Ratio5.3Lower Leverage y-yY
Price/Cash Flow34.9y-y EBITDA Growth Rate %123ROA % (ttm)26.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)44.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M108ROI % (ttm)23.1Gross Margin Increase y-yN

Gurus Latest Trades with EW

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EWVanguard Health Care Fund 2014-12-31 Reduce-0.21%$98.03 - $133.48
($120.7)
$ 139.9414%Reduce -19.13%3,402,670
EWRon Baron 2014-12-31 Reduce-0.11%$98.03 - $133.48
($120.99)
$ 139.9414%Reduce -31.07%576,836
EWVanguard Health Care Fund 2014-09-30 Reduce-0.16%$84.44 - $104.02
($94.89)
$ 139.9432%Reduce -14.48%4,207,470
EWRon Baron 2014-09-30 Reduce-0.08%$84.44 - $104.02
($94.89)
$ 139.9432%Reduce -22.73%836,867
EWJoel Greenblatt 2014-06-30 Add0.2%$72.97 - $87.86
($81.26)
$ 139.9442%Add 261.38%259,073
EWVanguard Health Care Fund 2014-06-30 Reduce-0.08%$72.97 - $87.86
($81.22)
$ 139.9442%Reduce -7.59%4,920,000
EWRon Baron 2014-06-30 Reduce-0.08%$72.97 - $87.86
($81.26)
$ 139.9442%Reduce -20.04%1,083,004
EWJoel Greenblatt 2014-03-31 Reduce-0.07%$64.17 - $73.93
($69.04)
$ 139.9451%Reduce -39.12%71,689
EWVanguard Health Care Fund 2013-12-31 Add0.83%$61.44 - $78.14
($67.6)
$ 139.9452%Add 306.07%5,324,000
EWRon Baron 2013-12-31 Reduce-0.21%$61.44 - $78.14
($67.6)
$ 139.9452%Reduce -29.66%1,533,972
EWJoel Greenblatt 2013-12-31 Add0.13%$61.44 - $78.14
($67.6)
$ 139.9452%Add 278.76%117,760
EWJoel Greenblatt 2013-09-30 Reduce-0.03%$65.25 - $73.4
($70.25)
$ 139.9450%Reduce -26.19%31,091
EWRon Baron 2013-06-30 Add0.4%$62.54 - $84.93
($71.02)
$ 139.9449%Add 135.69%1,985,766
EWMeridian Funds 2013-06-30 Add0.33%$62.54 - $84.93
($71.02)
$ 139.9449%Add 33.69%506,700
EWVanguard Health Care Fund 2013-06-30 Buy 0.32%$62.54 - $84.93
($71.02)
$ 139.9449%New holding1,311,100
EWJoel Greenblatt 2013-06-30 Add0.1%$62.54 - $84.93
($71.02)
$ 139.9449%Add 526.16%42,122
EWMeridian Funds 2013-03-31 Add0.11%$78.66 - $94.56
($88)
$ 139.9437%Add 11.14%379,000
EWJoel Greenblatt 2013-03-31 Add0.01%$78.66 - $94.56
($88)
$ 139.9437%Add 35.68%6,727
EWMeridian Funds 2012-12-31 Reduce-0.79%$83.7 - $109.75
($89.78)
$ 139.9436%Reduce -37.67%341,000
EWRon Baron 2012-12-31 Reduce-0.15%$83.7 - $109.75
($89.78)
$ 139.9436%Reduce -20.52%828,833
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EW is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


EW: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WANG HUIMINCVP, Japan & Intercontinental 2015-04-06Sell6,920$140.242.04view
Wood Larry LCVP, THV Replacement 2015-04-01Sell7,680$142.060.73view
MUSSALLEM MICHAEL AChairman & CEO 2015-03-26Sell29,500$140.12.14view
WANG HUIMINCVP, Japan & Intercontinental 2015-03-05Sell6,920$135.65.53view
Wood Larry LCVP, THV Replacement 2015-03-02Sell7,680$132.627.9view
Verguet Patrick BCVP, Europe 2015-02-26Sell10,000$134.756.2view
MUSSALLEM MICHAEL AChairman & CEO 2015-02-26Sell29,500$134.536.37view
Verguet Patrick BCVP, Europe 2015-02-19Sell5,000$134.56.39view
Wood Larry LCVP, THV Replacement 2015-02-06Sell7,680$134.796.17view
WANG HUIMINCVP, Japan & Intercontinental 2015-02-06Sell6,920$134.796.17view

Press Releases about EW :

    Quarterly/Annual Reports about EW:

    News about EW:

    Articles On GuruFocus.com
    Vanguard Health Care Fund's Undervalued Stocks Apr 03 2015 
    Fairly Valued Long-Term Performer – Edwards Lifesciences Mar 23 2015 
    East West Petroleum to Renew Normal Course Issuer Bid Jan 27 2015 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    East West Petroleum Provides Operational Update Dec 16 2014 
    Edwards Lifesciences Invests $50 Million in New Heart Failure Technology Dec 10 2014 
    East West Petroleum Announces Drilling of Cheal-E6 Well in New Zealand Nov 26 2014 
    East West Petroleum Grants Stock Options Nov 14 2014 
    East West Petroleum Provides Operational Update for New Zealand Nov 05 2014 
    East West Petroleum Announces Results of Annual General Meeting Oct 15 2014 


    More From Other Websites
    Edwards Lifesciences To Host Earnings Conference Call On April 23, 2015 Apr 10 2015
    Edwards Lifesciences To Host Earnings Conference Call On April 23, 2015 Apr 10 2015
    Thoratec Wins FDA Consent to Expand HeartMate III US Trial - Analyst Blog Apr 06 2015
    4 Good Investments for Good Friday - Analyst Blog Apr 02 2015
    IDEXX Banks on Strong CAG, Global Growth Continues - Analyst Blog Apr 01 2015
    Inogen Fails 10-K Deadline; Files Form 12b-25 for Extra Time - Analyst Blog Apr 01 2015
    Varian Medical: A Strong Sell on Tepid View, Estimate Revision - Analyst Blog Apr 01 2015
    Luminex (LMNX) Commences Clinical Trials for ARIES System - Analyst Blog Mar 31 2015
    Cepheid Ships Record Xpert MTB/RIF to Mark World TB Day - Analyst Blog Mar 30 2015
    Varian (VAR) Showcases Edge Radiosurgey at 2015 ChinaMed - Analyst Blog Mar 27 2015
    Cepheid's Xpert Ebola Gets FDA's Nod for Emergency Use - Analyst Blog Mar 27 2015
    Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Medical, Hologic... Mar 27 2015
    Why Edwards Lifesciences (EW) is Poised to Beat Earnings Estimates Again - Tale of the Tape Mar 27 2015
    Inogen's Texas Facility Ready, Costs Likely to Scale Down - Analyst Blog Mar 26 2015
    Abiomed Attains New 52-Week High on Impella 2.5 Approval - Analyst Blog Mar 25 2015
    Abiomed's Impella 2.5 FDA-Approved for PCI Procedures - Analyst Blog Mar 24 2015
    Edwards' CEO Addresses Senate Committee On Preserving And Strengthening Medical Device Innovation In... Mar 24 2015
    Edwards' CEO Addresses Senate Committee On Preserving And Strengthening Medical Device Innovation In... Mar 24 2015
    Varian Opens New Unit in Algeria, Consolidates in North Africa - Analyst Blog Mar 19 2015
    Edwards Lifesciences Up on Positive PARTNER Trial Data - Analyst Blog Mar 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK